Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors (Q37932525)

25 August 2017

1 reference

title

Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors (English)

1 reference

25 August 2017

1 reference

Jonathan L Bramson

0 references

Jennifer D Bassett

1 reference

25 August 2017

Stephanie L Swift

series ordinal

1 reference

25 August 2017

publication date

1 September 2011

1 reference

Expert Review of Vaccines

25 August 2017

published in

1 reference

25 August 2017

1 reference

25 August 2017

1 reference

25 August 2017

page(s)

1307-1319

1 reference

Immunological memory to viral infections.

25 August 2017

cites work

1 reference

Vaccinia virus vaccines: past, present and future

21 January 2018

1 reference

That Was Then But This Is Now: Malaria Research in the Time of an Eradication Agenda

21 January 2018

1 reference

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age

21 January 2018

1 reference

Tuberculosis: what we don't know can, and does, hurt us.

21 January 2018

1 reference

New vaccines for tuberculosis

21 January 2018

1 reference

Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans

21 January 2018

1 reference

Global trends in emerging infectious diseases

21 January 2018

1 reference

New frontiers in cell-based immunotherapy of cancer.

21 January 2018

1 reference

Therapeutic cancer vaccines: are we there yet?

21 January 2018

1 reference

Recent developments in cancer vaccines

21 January 2018

1 reference

Current developments in adenovirus-based cancer gene therapy

21 January 2018

1 reference

Can successful vaccines teach us how to induce efficient protective immune responses?

21 January 2018

1 reference

Vaccines: correlates of vaccine-induced immunity

21 January 2018

1 reference

Measles antibody: reevaluation of protective titers

21 January 2018

1 reference

Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus

21 January 2018

1 reference

On natural and artificial vaccinations

21 January 2018

1 reference

Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location

21 January 2018

1 reference

T cells in mycobacterial infection and disease

21 January 2018

1 reference

Rational design of vaccines against tuberculosis directed by basic immunology

21 January 2018

1 reference

Gamma interferon responses of CD4 and CD8 T-cell subsets are quantitatively different and independent of each other during pulmonary Mycobacterium bovis BCG infection

21 January 2018

1 reference

Murine airway luminal antituberculosis memory CD8 T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment

21 January 2018

1 reference

Wanted, dead or alive: New viral vaccines

21 January 2018

1 reference

Adenoviruses as vaccine vectors

21 January 2018

1 reference

An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method

21 January 2018

1 reference

Development of nonhuman adenoviruses as vaccine vectors

21 January 2018

1 reference

New insights on adenovirus as vaccine vectors

21 January 2018

1 reference

International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials

21 January 2018

1 reference

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

21 January 2018

1 reference

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults

21 January 2018

1 reference

Viruses as vaccine vectors for infectious diseases and cancer

21 January 2018

1 reference

Phase I clinical trial of an adenovirus/prostate-specific antigen vaccine for prostate cancer: safety and immunologic results.

21 January 2018

1 reference

Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults

21 January 2018

1 reference

Detailed analysis of the CD8+ T-cell response following adenovirus vaccination

21 January 2018

1 reference

Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

21 January 2018

1 reference

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei

21 January 2018

1 reference

Persistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirus

21 January 2018

1 reference

Gammaherpesvirus persistence alters key CD8 T-cell memory characteristics and enhances antiviral protection

21 January 2018

1 reference

Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys

21 January 2018

1 reference

Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates

21 January 2018

1 reference

Vaccine-induced T cells provide partial protection against high-dose rectal SIVmac239 challenge of rhesus macaques

21 January 2018

1 reference

Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells

21 January 2018

1 reference

Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive

21 January 2018

1 reference

Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionality

21 January 2018

1 reference

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

21 January 2018

1 reference

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

21 January 2018

1 reference

Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets

21 January 2018

1 reference

Lineage relationship and protective immunity of memory CD8 T cell subsets

21 January 2018

1 reference

Unidirectional development of CD8+ central memory T cells into protective Listeria-specific effector memory T cells.

21 January 2018

1 reference

Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge

21 January 2018

1 reference

Memories that last forever: strategies for optimizing vaccine T-cell memory

21 January 2018

1 reference

Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection

21 January 2018

1 reference

T cell vaccines for microbial infections

21 January 2018

1 reference

Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys

21 January 2018

1 reference

T-cell quality in memory and protection: implications for vaccine design

21 January 2018

1 reference

Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

21 January 2018

1 reference

Immune exhaustion: driving virus-specific CD8+ T cells to death

21 January 2018

1 reference

Viral immune evasion due to persistence of activated T cells without effector function

21 January 2018

1 reference

Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment

21 January 2018

1 reference

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

21 January 2018

1 reference

Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control

21 January 2018

1 reference

Magnitude and quality of vaccine-elicited T-cell responses in the control of immunodeficiency virus replication in rhesus monkeys

21 January 2018

1 reference

Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control

21 January 2018

1 reference

Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses

21 January 2018

1 reference

Memory CD8+ T cells mediate antibacterial immunity via CCL3 activation of TNF/ROI+ phagocytes.

21 January 2018

1 reference

A role for TNF in limiting the duration of CTL effector phase and magnitude of CD8 T cell memory.

21 January 2018

1 reference

New insights into the regulation of T cells by gamma(c) family cytokines

21 January 2018

1 reference

Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.

21 January 2018

1 reference

Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells

21 January 2018

1 reference

Migration, maintenance and recall of memory T cells in peripheral tissues

21 January 2018

1 reference

Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation

21 January 2018

1 reference

Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration

21 January 2018

1 reference

In situ imaging reveals different responses by naïve and memory CD8 T cells to late antigen presentation by lymph node DC after influenza virus infection

21 January 2018

1 reference

Antigen-independent memory CD8 T cells do not develop during chronic viral infection

21 January 2018

1 reference

Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection

21 January 2018

1 reference

Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection

21 January 2018

1 reference

Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection.

21 January 2018

1 reference

Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells.

21 January 2018

1 reference

Homeostatic proliferation and survival of naïve and memory T cells

21 January 2018

1 reference

Evolution of diverse antiviral CD8+ T cell populations after murine cytomegalovirus infection.

21 January 2018

1 reference

Local advantage: skin DCs prime; skin memory T cells protect

21 January 2018

1 reference

Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus

21 January 2018

1 reference

Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity

21 January 2018

1 reference

Cutting edge: contribution of lung-resident T cell proliferation to the overall magnitude of the antigen-specific CD8 T cell response in the lungs following murine influenza virus infection

21 January 2018

1 reference

Dynamic T cell migration program provides resident memory within intestinal epithelium

21 January 2018

1 reference

Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence

21 January 2018

1 reference

Herpes Simplex Virus-Specific Memory CD8+ T Cells Are Selectively Activated and Retained in Latently Infected Sensory Ganglia

21 January 2018

1 reference

Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs

21 January 2018

1 reference

CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells.

21 January 2018

1 reference

Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection

21 January 2018

1 reference

Unconventional antigen-presenting cells in the induction of peripheral CD8(+) T cell tolerance

21 January 2018

1 reference

CD70+ antigen-presenting cells control the proliferation and differentiation of T cells in the intestinal mucosa

21 January 2018

1 reference

Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes

21 January 2018

1 reference

Latent species C adenoviruses in human tonsil tissues

21 January 2018

1 reference

Host immune responses to chronic adenovirus infections in human and nonhuman primates.

21 January 2018

1 reference

Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation

21 January 2018

1 reference

Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells

21 January 2018

1 reference

Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes

21 January 2018

1 reference

Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses

21 January 2018

1 reference

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination

21 January 2018

1 reference

The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells

21 January 2018

1 reference

In vitro dendritic cell infection by pseudotyped adenoviral vectors does not correlate with their in vivo immunogenicity

21 January 2018

1 reference

Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells

21 January 2018

1 reference

High efficiency transduction of dendritic cells by adenoviral vectors targeted to DC-SIGN.

21 January 2018

1 reference

Significant alterations of biodistribution and immune responses in Balb/c mice administered with adenovirus targeted to CD40(+) cells

21 January 2018

1 reference

The influence of adenovirus fiber structure and function on vector development for gene therapy

21 January 2018

1 reference

Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin

21 January 2018

1 reference

Enhanced and Sustained CD8+ T Cell Responses with an Adenoviral Vector-Based Hepatitis C Virus Vaccine Encoding NS3 Linked to the MHC Class II Chaperone Protein Invariant Chain

21 January 2018

1 reference

Dendritic Cell-Specific Antigen Delivery by Coronavirus Vaccine Vectors Induces Long-Lasting Protective Antiviral and Antitumor Immunity

21 January 2018

1 reference

Novel adenovirus vector-based vaccines for HIV-1

21 January 2018

1 reference

Prime-boost vectored malaria vaccines: progress and prospects

21 January 2018

1 reference

Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis

21 January 2018

1 reference

Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis

21 January 2018

1 reference

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates

21 January 2018

1 reference

Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses

21 January 2018

1 reference

Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimens

21 January 2018

1 reference

A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).

21 January 2018

1 reference

Protective efficacy of a single immunization of a chimeric adenovirus vector-based vaccine against simian immunodeficiency virus challenge in rhesus monkeys

21 January 2018

1 reference

The role of mTOR in memory CD8 T-cell differentiation

21 January 2018

1 reference

mTOR regulates memory CD8 T-cell differentiation

21 January 2018

1 reference

TOR signaling in growth and metabolism

21 January 2018

1 reference

Enhancing CD8 T-cell memory by modulating fatty acid metabolism

21 January 2018

1 reference

4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine.

21 January 2018

1 reference

Immunologic Basis of Vaccine Vectors

21 January 2018

1 reference

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys

21 January 2018

1 reference

An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study)

21 January 2018

1 reference

Replacement of native adenovirus receptor-binding sites with a new attachment moiety diminishes hepatic tropism and enhances bioavailability in mice

21 January 2018

1 reference

An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity

21 January 2018

1 reference

Recombinant Adenovirus Vaccines Can Successfully Elicit CD8+ T Cell Immunity under Conditions of Extreme Leukopenia

21 January 2018

1 reference

Dendritic Cell-Induced Memory T Cell Activation in Nonlymphoid Tissues

21 January 2018

1 reference

Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy Adults

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.11.88

1 reference

25 August 2017

1 reference